Oncology & Cancer

Novel bioassay predicts cancer patients' response to immunotherapy

A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, ...

Medical research

Why new cancer treatment discoveries are proliferating

In the five years since the FDA's initial approval of chimeric antigen receptor (CAR) T cell therapy, Penn Medicine has gleaned 20 additional approvals related to drugs and techniques to treat or detect cancer.

page 10 from 40